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Abstract 
Health care disparities associated with African American race may influence event-free 
survival in patients with heart failure (HF).  A secondary data analysis included 863 
outpatients enrolled in a multicenter HF registry. Cox regression was used to determine 
whether African American race was associated with shorter HF event-free survival after 
controlling for covariates. The multivariable-adjusted hazard ratios (95% confidence 
intervals) of older age 1.03 (95% confidence intervals [CI] 1.01, 1.04), NYHA functional 
class 1.73 (95% CI 1.29, 2.31), depressive symptoms 1.05 (95% CI 1.02, 1.07), and 
African American race 1.64 (95% CI 1.01, 2.68) were predictors of shorter event-free 
survival (all p<.05). Comparisons showed that NYHA functional class was predictive of 
shorter event-free survival in Caucasians 1.81 (95% CI 1.33, 2.46) but not in African 
Americans 1.24 (95% CI .40, 3.81). African Americans with HF experienced a disparate 
risk of shorter event-free survival not explained by a variety of risk factors.  
Keywords: Health disparities, heart failure, race  
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African American Race is Associated with Poorer Outcomes in Heart Failure 
Patients 
Health outcomes for patients with heart failure (HF) have trended both positively 
and negatively in the last two decades, depending on which is the outcome of interest. 
From 1993 to 2006, patients with HF experienced reductions in hospital lengths of stay 
and mortality, but at the cost of increasing number and frequency of hospitalizations 
(Bueno et al., 2010). From 2000 to 2010, there were no changes in rates of HF 
hospitalizations (Go et al., 2013) with one in four (24%) patients readmitted within 30 
days of hospital discharge (Ross et al., 2010).  
The HF cost burden is largely tied to unanticipated hospitalizations during the 30-
day post-discharge period brought on by disease exacerbations (American Heart 
Association, 2012). As a major public health concern, HF leads annual health care 
expenditures in the United States, costing $39.2 billion dollars annually while affecting 
5.8 million patients (American Heart Association, 2012). One method of capturing the 
impact of utilization is with event-free survival, or the amount of time to a first negative 
health event such as emergency department use, hospitalization, or death (Wu et al., 
2010). Longer periods of time to a negative health event generally indicate better 
individual outcomes as well as decreased cost burden (Ross et al., 2010). 
There are many known risk factors that can contribute to poor outcomes in 
patients with HF. Measures of increased disease severity in patients with HF correlate 
with increased risk for mortality and use of health care services (Karasek, Widimsky, 
Ostadal, Hrabakova, & Penicka, 2012). Patients are more likely to experience shorter 
event-free survival if they are of African American race (Wu et al., 2010), increased age 
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(Bagchi, Stewart, McLaughlin, Higgins, & Croghan, 2011; Karasek et al., 2012; 
Saczynski et al., 2009), low income and education (Hawkins, Jhund, McMurray, & 
Capewell, 2012; Roe-Prior, 2007), have high levels of depressive symptoms (Chung, 
Lennie, Dekker, Wu, & Moser, 2011), high levels of anxiety (De Jong et al., 2011), high 
levels of stress (Chung et al., 2011), or low levels of adherence (Son, Lee, & Song, 2011; 
Song, 2009; Wu et al., 2010). Researchers have reported individual and grouped 
contributions of these risk factors. Despite this research, it is not well understood how 
sociodemographic, psychosocial, disease factor, and treatment contributions impact HF 
event-free survival when examined together.  
Understanding subpopulations is a critical step towards improving outcomes in 
patients with HF. This understanding is particularly relevant to African American 
patients, as they use more urgent care resources and have rates of HF readmissions far 
exceeding those of Caucasians (Menash, Mokdad, Ford, Greenlund, & Croft, 2005; 
Philbin & DiSalvo, 1998; Roe-Prior, 2007; Wu et al., 2010). The limited evidence 
regarding this specific vulnerable population reveals lower rates of adherence and poorer 
event-free survival in African American as compared to Caucasian patients with HF (Wu 
et al., 2010). One study examining the racial disparity of adherence in HF patients found 
that African American patients have 32% lower rates of medication adherence compared 
with Caucasian patients (Wu et al., 2010). The lack of understanding relative to HF 
outcomes in African Americans highlights a clear gap in the empirical literature. For 
these reasons it is important that we determine the extent of the disparity in HF event-free 
survival between African American and Caucasian patients. 
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The limited evidence that we have so far suggests that African American patients 
are experiencing worse event-free survival.  The purpose of this study was to validate this 
claim and seek clarity on the relationship between African American and Caucasian 
ethnicities and HF event-free survival. Specifically, the aim of this project was to 
determine whether ethnicity is an independent predictor of HF event-free survival 
(defined as time to HF hospitalization, emergency department visit for HF, or HF death) 
among patients with HF, controlling for age, gender, body mass index (BMI), smoking, 
interventions, New York Heart Association (NYHA) functional class, ejection fraction, 
and depressive symptoms. A secondary aim of this study was to determine if African 
Americans with HF have different predictors of HF event-free survival than Caucasians. 
Methods 
Data Source 
This study was conducted as a secondary data analysis of the Heart Failure 
Quality of Life Registry, which combined data from research studies across the United 
States (see Table 1). Detailed registry procedures and methods are presented in detail 
elsewhere (Dekker et al., 2014; Dracup et al., 2014; Lee, Lennie, Wu, Biddle, & Moser, 
2014; Moser et al., 2013). Participants were enrolled in both intervention and non-
intervention studies capturing event-free survival in patients with HF along with various 
covariate and independent variables. All participants provided informed consent and all 
parent projects were monitored by human subjects review boards. 
Sample and Setting 
Data were analyzed from 863 outpatients enrolled in a multicenter HF registry 
who were followed for a median of 1.9 years (37% female, 10.5% African American, 
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64±13 years, 38% NYHA Class III/IV). Patients were eligible if they had a confirmed 
diagnosis of HF, were English speaking, were living at home and not in an institution, 
and were patients in a cardiology clinic or had been hospitalized for HF within the 
previous 12 months. Patients were excluded if they had serious life-threatening co-
morbidity or severely impaired cognition that would prevent independent self-care. 
Recruitment took place in California, Indiana, Kentucky, and Nevada. 
Participants within the registry data set were enrolled in intervention and non-
intervention studies.  The purposes and interventions within these projects are detailed 
elsewhere and an overview presented in Table 1. The presence of an intervention was 
controlled for in this secondary data analysis. 
Participants were eligible for inclusion in this secondary data analysis if they had 
complete data for variables in the primary analysis.  All participants also had complete 
follow-up event data. Additionally, participants from only the self-identified Caucasian 
and African American ethnicities were included because there were too few participants 
in other ethnic groups for analysis. 
Measures 
Predictors of shorter HF event-free survival 
Heart failure event-free survival predictors of particular importance are those 
regarding disease severity, treatment, and other health factors such as comorbidity and 
psychological distress.  Parent studies included a variety of these predictors of poorer HF 
event-free survival. To maintain power with the limited number of African American 
participants, predictors for the main analysis were selected to maintain a maximum 
sample of African American participants.  Further narrowing of variables was necessary 
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particularly in terms of HF disease characteristics. Disease characteristics of NYHA class 
and ejection fraction were chosen for final analysis over other characteristics such as 
etiology. Variables selected for inclusion include age, gender, BMI, smoking, inclusion in 
an intervention, ejection fraction, NYHA functional class, and depressive symptoms. 
Additional variables were measured to describe the sample.  
Data on demographics, including age, gender, marital status, race and ethnicity 
were collected for each participant using self-report. Additionally smoking status, 
comorbid conditions, BMI, current medications, ejection fraction, and cardiac event data 
were all collected via chart review and interview. NYHA class was determined by patient 
interview.  
As depressive symptoms are a key indicator of poor event-free survival in patients 
with HF (Chung et al., 2011; Wu et al., 2013), patients included in the study had 
completed a depressive symptom scale. Depressive symptoms were measured with the 
Patient Health Questionaire-9 (PHQ-9). The PHQ-9 is a 9-item measure developed based 
on the 9 criteria for diagnosis of depressive disorders in line with the Diagnostic and 
Statistical Manual of Mental Disorders (Kroenke & Spitzer, 2002). This scale presents 
severity of depressive symptoms from 0-27 with higher numbers representing more 
severe symptoms. Cut points of 5 indicate mild, 10 moderate, 15 moderately severe, and 
20 severe depressive symptoms (Kroenke & Spitzer, 2002).  
Outcome variable 
The outcome variable of HF event-free survival was measured and was calculated 
as time to the first occurrence of a negative HF health event defined as HF 
hospitalization, HF emergency department visit, or death from HF causes. Patients were 
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called monthly for the first year, and then followed by medical record review for up to 
3.5 years to collect data about event-free survival. All self-reported events were verified 
with hospital records, and all deaths were verified with medical record review or death 
certificate review. Trained cardiovascular advanced practice research nurses who were 
blinded to demographics and other variables collected data on event-free survival data. 
Two principal investigators on the Registry team adjudicated ambiguous events.  
Data Analysis 
Demographic variables of gender, age, marital status, education level and clinical 
variables of depressive symptoms, body mass index (BMI), NYHA functional class, 
ejection fraction, preservation of systolic function, etiology of HF, smoking status, and 
months since diagnosis were used to describe the sample. Descriptive examination of 
variables was completed, including frequency distributions, means, standard deviations, 
medians, and interquartile ranges, as appropriate to the level of measurement of the 
variables. Alpha was set at .05.   
We used Cox proportional hazards regression modeling to determine whether 
African American ethnicity was associated with shorter HF event-free survival, 
controlling for the covariates of age, gender, BMI, smoking, inclusion in an intervention, 
ejection fraction, NYHA functional class, and depressive symptoms. For the second 
specific aim, we conducted Cox proportional hazard regression modeling for Caucasian 
and African American participants separately controlling for the above mentioned 
covariates. 
Results 
Participants 
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From the Registry data set, 863 individuals met inclusion criteria for this study. 
Sample characteristics are outlined in Table 2. Overall, participants were mostly male 
(63%), 64.1 ± 12.7 years of age, 10.5% were African American, and 38% were NYHA 
Class III/IV.  The mean PHQ-9 score was 6.7 ± 6.0 with good internal validity in the 
African American sample with Cronbach alpha =.874. 
African American participants were younger, M=57.0 SD=9.8 years, compared to 
Caucasians, M=65.0 SD=12.7, and were more likely to be smokers (p<.001).  Additional 
differences noted in this sample were that there was a higher percentage of females 
among African American participants compared to Caucasian participants (p<.001), and a 
lower percentage of married African American participants (p<.001). The African 
American participants also had a smaller proportion with ischemic etiology HF compared 
to Caucasian participants (p<.001).  
Of the patients included in this analysis, 3 (0.4%) died of HF causes, all of these 
individuals were Caucasian. Patients hospitalized for HF reasons were the most common 
HF event (n=185, 21.4%). Of those hospitalized for HF, 164 were Caucasian and 21 were 
African American.  Eight patients (0.9%) visited the emergency department for HF 
reasons over the follow-up period, with all of these individuals also being Caucasian.    
Differences in HF Event-Free Survival 
Among the entire sample, age, ethnicity, and depressive symptoms were all 
predictors of shorter HF event-free survival in multivariable-adjusted hazard ratios (95% 
confidence intervals, all p<.05; See Table 3).  Hazard ratios after adding ethnicity in 
block 2 (95% confidence intervals) indicate the strength of these relationships, with older 
age increasing the hazard of a negative health event of 1.03 (1.01, 1.04), African 
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American ethnicity at 1.64 (1.01, 2.68), higher NYHA functional classification at 1.73 
(1.29, 2.31), and incrementally increasing depressive symptoms at 1.05 (1.02, 1.07). 
 Survival curves indicated a shorter HF event-free survival for African American 
participants (See Figure 1). Importantly, these survival curves account for the controlled 
covariates (age, gender, BMI, smoking, presence of an intervention, ejection fraction, 
NYHA functional class, and depressive symptoms).  African American participants 
experienced poorer HF event-free survival at nearly all time points within the curves, an 
almost immediate substantial downward trend is seen on the survival curve in African 
American time to their first health event occurs as compared to the curves of Caucasians. 
These results suggest that African Americans with HF experienced a disparate risk of 
cardiac events not explained by clinical, demographic or psychological risk factors.  
To aid in explaining these differences, a second Cox regression model 
demonstrates the differences between contributing factors separated by ethnicity.  In the 
Caucasian patients, age, NYHA functional class, and depressive symptoms were all 
predictors of shorter HF event-free survival in multivariable-adjusted hazard ratios (95% 
confidence intervals, all p<.05) (See Table 4).  As a comparison, in African American 
patients, only age and depressive symptoms were predictors of the same outcome. Hazard 
ratios (95% confidence intervals) indicate that older age increased the hazard of a 
negative health event by 1.03 (1.01, 1.04) in Caucasian patients and 1.07 (1.02-1.12) in 
African American patients. Incrementally increasing depressive symptoms was at 1.04 
(1.02,1.07) in Caucasians and 1.09 (1.02-1.18) in African American patients. With 
NYHA functional classification, significance was only found with Caucasians 
demonstrating hazard ratios at 1.81 (1.33, 2.46).  
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Discussion 
The primary finding of this study was that African American patients experienced 
disparate shorter HF event-free survival rates that were not explained by a host of 
potential risk factors. Of additional importance is the clear indication that African 
American patients with HF experience negative health events sooner than Caucasian 
patients with HF. It is critical that additional attention is drawn to this disparity and 
potential resolutions be explored. 
Risk Factors 
African American patients in this study experienced higher rates of known risk 
factors of HF than did Caucasian patients.  This is primarily that the African American 
patients were more likely to be smokers (p<.001). The increased prevalence of smoking 
in the African American patients did not explain the differences in HF event-free 
survival. Neither ethnic group demonstrated an increased hazard ratio of poorer HF 
event-free survival in the presence of smoking.   
Body mass index in this study was not significantly different between the African 
American and Caucasian group, and was not significant in predicting HF event-free 
survival. In another study of patients with HF, waist circumference and BMI are each 
examined and show that better outcomes are seen with both higher waist circumference 
and higher BMI (Clark, Fonarow, & Horwich, 2011). Our study does not support the 
obesity paradox that is commonly reported among patients with HF.  
Contributors to Poorer Event-Free Survival 
Age and higher levels of depressive symptoms were shown to impact HF event-
free survival in this population.  This significance remains when examining Caucasian 
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and African American participants separately. The impact of increasing age on decreased 
HF event-free survival (p<0.001) in this study is consistent with the literature.  
In discussing the variables of impact in HF event-free survival in this study, it is 
important to consider the impact seen with depression.  Higher depressive symptoms are 
1.3 times more prevalent in African Americans than in Caucasians (Bromberger, Harlow, 
Avis, Kravitz, & Cordal, 2004) and negatively impact adherence (Luyster, Hughes, & 
Gunstad, 2009; Song, 2009). In this study we see that depressive symptoms are an 
independent predictor of decreased HF event-free survival (p<0.001). The increased 
prevalence of depressive symptoms in African American patients (Bromberger et al., 
2004), paired with the results in this study, indicates that addressing depression is critical.  
Although NYHA functional classification was a predictor in the overall model, 
the comparison model shows that this variable is only significantly related to poorer HF 
event-free survival in Caucasian participants. 
By approaching the known patient contributors to decreased HF event-free 
survival, care can be focused on these variables and those patients exhibiting multiple 
risk factors.  Changes to care may include utilizing the risk factors identified to target at 
risk populations and to intervene on the modifiable risk factors. Reviews of risk factors 
(Giamouzis et al., 2011) in addition to new empirical evidence such as this project can 
aid in the development of a much needed risk assessment tool for patients with HF 
(Betihavas et al., 2012). The development of a risk assessment tool would aid clinicians 
in identifying at risk populations and potentially burdensome modifiable risk factors.    
Well known to clinicians is the importance of treating HF directly to decrease HF 
severity and prevent worsening of the disease. Less evident is the impact of other 
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modifiable risk factors on outcomes of HF such as treating depression. Increasing 
depressive symptoms in this study was a significant contributor to diminishing HF event-
free survival. Other research has found evidence that those patients with depression in 
remission experience improved cardiovascular outcomes (Jiang et al., 2011). By treating 
comorbid conditions, particularly depression, and other modifiable risk factors noted in 
this analysis there may be improvements in HF outcomes. Modifiable risk factors such as 
prevention and treatment of HF severity and depression need to be a focus of clinicians. 
There are many non-modifiable risk factors that cannot be directly intervened upon. This 
study found in particular that older age and African American ethnicity are predictors of 
poorer HF event free survival. These non-modifiable risk factors can be used to target 
interventions and resources in these vulnerable populations.   
Such a striking disparity in the outcome of African Americans with HF raises the 
question as to what beyond patient contributors accounts for the negative outcomes.  
With the increased prevalence of HF risk factors seen in this population unexplained 
variance in event-free survival, it is important to consider the possibility of social issues 
and their negative impact in African American patients.  
The disparities of African American patients in event-free survival are not unique 
to HF.  A large body of research has demonstrated that African American patients in 
general have increased challenges accessing and receiving quality healthcare (Institute of 
Medicine, 2001; Schoenfeld, Tipirneni, Nelson, Carpenter, & Iwashyna, 2014). Given 
that we were unable to find any clinical factors that explained the shorter HF event-free 
survival of African American patients with HF, research is needed to explore non-patient 
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contributors to the disparities in health outcomes experienced by this vulnerable 
population.  
Conclusion 
African American race is an important predictor in event-free survival of patients 
with HF.  Correcting the discriminatory gap between Caucasian and African American 
patients is highly complex.  The multifaceted relationship between the population risk 
factors includes both non-patient as well as patient contributors.  These distinct 
contributions can be approached from an individual and a population perspective.  By 
using the known risk factors of decreased HF event-free survival, resources can be 
targeted at the most vulnerable individuals.  Research should be focused on developing 
risk assessment tools to identify vulnerable HF patients.  Additionally, research is needed 
to improve interventions specific to the vulnerable population of African American 
patients with HF and in addressing the impact of systematic racism on health of 
vulnerable populations.  
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Table 1.  
 
Description of Individual Studies from the HF Registry 
 
Study Purpose Design and Sample Intervention 
Determine the mechanisms 
underlying the relationship 
between depression, 
anxiety, and shorter event-
free survival in patients 
with HF (AACN) 
Prospective, 
longitudinal study 
N = (75) outpatients 
with HF in Kentucky 
No intervention 
Test the effects of cognitive 
behavior therapy and 
biofeedback on outcomes 
in patients with HF (BFD) 
Randomized, 
controlled trial 
N = (182) outpatients 
with HF in Kentucky 
Intervention = 6 weekly sessions of biofeedback 
training and cognitive behavior therapy with a 
psychiatric nurse practitioner 
Sham Intervention = 6 weekly talk sessions with a 
psychiatric nurse practitioner 
Usual care = No visits with the psychiatric nurse 
practitioner 
Determine the relationship 
between body mass index 
and event-free survival in 
outpatients with HF 
Prospective, 
longitudinal study 
N = (55) outpatients 
with HF from Kentucky, 
Indiana, and Georgia 
No intervention 
Test the effects of a self-
care education program on 
outcomes in rural patients 
with HF  
Randomized, 
controlled trial 
N = (551) outpatients 
from Kentucky, 
Nevada, and California 
There were two intervention groups: Fluid Watchers 
LITE and PLUS. Both intervention groups received 
counseling about HF and self-monitoring, and 
coaching on seeking care. The PLUS group also 
received additional counseling, audio tapes and 
telephone follow-up. There was also a usual care 
group that received usual care from their physician.  
Note. Individual studies are reported in “Coexisting anxiety and depressive symptoms in patients with heart 
failure” by R. Dekker, et al., (2014) in European Journal of Cardiovascular Nursing, 2014(13), p. 168-176; 
“Randomized controlled trial to improve self-care in patients with heart failure living in rural areas” by 
Dracup, et al., (2014) in Circulation, 130, p. 256-264; “Depressive symptoms, health-related quality of life, 
and cardiac event-free survival in patients with heart failure: A mediation analysis.” by Lee, Lennie, Wu, 
Biddle, & Moser (2014) in Quality of Life Research, 23(6), p. 1869-1876; and in “’It could be worse... Lot's 
worse!' Why health-related quality of life is better in older compared with younger individuals with heart 
failure” by Moser et al., (2013) in Age and Ageing, p. 626-632. 
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Figure 1. Survival Curves of African American and Caucasian Patients with HF 
 
Survival curve indicates the time to the first occurrence of a negative HF health event 
defined as HF hospitalization, HF emergency department visit, or death from HF 
causes; HF, Heart Failure. 
 
